Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03926598 · ClinicalTrials.gov registry record
Guide To Goals: A Novel Care Coordination Tool for Children With Type Two Diabetes (T2D)
A clinical trial of Type2 Diabetes Mellitus, sponsored by Georgia Institute of Technology.
- Completed
- Registry status
- 6
- Enrollment target
- 1
- Study location
NCT03926598 is a study of Type2 Diabetes Mellitus that has completed, run by Georgia Institute of Technology. The registered enrollment target is 6 participants, below the 7,067-participant average among 7 other Type2 Diabetes Mellitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03926598, a study of Type2 Diabetes Mellitus, has completed, sponsored by Georgia Institute of Technology.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The ultimate goal of this field trial is to systematically evaluate a novel care coordination tool for children with Type 2 Diabetes (T2D) in an office setting at Emory/Childrens Healthcare of Atlanta. The Guide to Goals (GTG) application was designed and developed at Georgia Institute of Technology with the aim of providing evidence-based information in a timely manner to all the stakeholders involved in the care of a T2D patient during an office visit
Conditions Studied
Interventions
- BEHAVIORAL Patient and/or Family Member Intervention
- BEHAVIORAL Certified Diabetes Educator Intervention
- BEHAVIORAL Physician Intervention
- BEHAVIORAL Front Desk Staff Intervention
- BEHAVIORAL Nurse Intervention
Study Locations (1)
Georgia
- Children's Helathcare of Atlanta - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-06-05 |
| Est. Completion | 2019-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03926598
The ClinicalTrials.gov registry entry for NCT03926598 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,067-participant average among 7 other Type2 Diabetes Mellitus trials with a reported enrollment target (100% lower). The listed sponsor is Georgia Institute of Technology, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type2 Diabetes Mellitus appearing as the primary indexed condition, and to 5 interventions - of which Patient and/or Family Member Intervention is the first listed.
NCT03926598 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT03926598 about?
NCT03926598 is a clinical study titled "Guide To Goals: A Novel Care Coordination Tool for Children With Type Two Diabetes (T2D)". The ultimate goal of this field trial is to systematically evaluate a novel care coordination tool for children with Type 2 Diabetes (T2D) in an office setting at Emory/Childrens Healthcare of Atlanta. The Guide to Goals (GTG) application was designed and developed at Georgia Institute of Technology...
What is the current status of trial NCT03926598?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2019-06-05. Estimated completion is 2019-08-30.
What conditions does trial NCT03926598 study?
This clinical trial studies the following conditions: Type2 Diabetes Mellitus.
What interventions are being tested in trial NCT03926598?
The interventions under investigation include: Patient and/or Family Member Intervention (BEHAVIORAL), Certified Diabetes Educator Intervention (BEHAVIORAL), Physician Intervention (BEHAVIORAL), Front Desk Staff Intervention (BEHAVIORAL), Nurse Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03926598?
This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03926598 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Chronotype: Impact on Sleep and Metabolism
ACTIVE NOT RECRUITING · NA
-
Effort During Resistance Training in Type 2 Diabetes
ACTIVE NOT RECRUITING · NA
-
Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
COMPLETED
-
Metabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes or Met Syn
COMPLETED · NA
-
Mil Familias-Santa Barbara's Operational Pilot to Understand Diabetes in the Latino Community
COMPLETED
-
Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.